Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
Знаете ли вы? Кликните два раза на слово, чтобы найти его в TermGallery.
Значения термина mimetic peptides на английском
Значения для термина "mimetic peptides" отсутствуют.
Использование термина mimetic peptides на английском
1
Purpose of review: To determine the potential clinical utility of high-density lipoprotein- mimeticpeptides.
2
ApoA-I and apoA-I mimeticpeptides appear to have significant therapeutic potential in atherosclerosis.
3
These HDL mimeticpeptides are much more effective in removing the oxidized phospholipids and other oxidized lipids.
4
These mimeticpeptides improve LDL and HDL composition and function and reduce lesion formation in animal models of atherogenesis.
5
Small-molecule inhibitors of anti-apoptotic Bcl-2 proteins and BH3 mimeticpeptides are promising anticancer agents.
6
Our findings also highlight the potential of developing apoE mimeticpeptides as novel HCV entry inhibitors by targeting HCV-host interactions.
7
Whether HDL mimeticpeptides will have therapeutic benefit in patients with renal failure will have to be determined in clinical studies.
8
Taken together, the results indicate that connexin- mimeticpeptides block electrical signaling in rat mesenteric small arteries without exerting major nonjunctional effects.
9
In animal models and perhaps in humans, dysfunctional HDL can be improved by apoA-I mimeticpeptides that bind oxidized lipids with high affinity.
10
This finding led to the design of short receptor dimer interface mimeticpeptides that block the binding of superantigen and thus protect from death.
11
Following is a brief description of some of the HDL mimeticpeptides that can improve HDL and the effect of the peptide on PON1 activity.
12
This review focuses on the preclinical and clinical findings for two types of therapies for the treatment of atherosclerosis: apoAI-containing compounds and apoAI mimeticpeptides.
13
We have developed apoA-I mimeticpeptides that are much smaller than apoA-I, and much more effective in removing the oxidized phospholipids and other oxidized lipids.
14
Purpose of review: Recent publications related to the potential use of apolipoprotein (apo)A-I and apoA-I mimeticpeptides in the treatment of atherosclerosis are reviewed.
15
Our group has developed apoA-I mimeticpeptides that are much smaller than apoA-I (18 amino acids long vs 243 in ApoA-I itself).